BIOIX:NASDAQ
Baron Opportunity Fund Institutional Class – BIOIX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 56.14 | 0.21 (+0.38%) | 39.63 - 56.89 | 0.0 |
Market data as of 12:00AM 08/18/25. Quotes are delayed by at least 15 min.
Overview - BIOIX
The investment seeks capital appreciation through investments primarily in growth companies that benefit from technology advances.
The fund invests primarily in equity securities in the form of common stock of U.S. high growth businesses of any market capitalization selected for their capital appreciation potential. The Adviser may invest in companies in any sector or industry that the adviser believes will benefit from innovations and advances in technology.
Growth of $10,000 (10 Years)
| Total Return | 17.82% |
|---|
| Yield (Trailing 12 Mo.) | 0.00% |
|---|
| Expense Ratio | 1.05% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $1,000,000 |
|---|
| Management Tenure | 19 Years |
|---|
| Fund Inception | 05/29/2009 |
|---|
Trailing Total Returns - BIOIX
as of 07/31/2025
| Timeframe | BIOIX | S&P 500 | Large Growth |
|---|
| 1 Month | 3.21% | 2.24% | 2.55% |
|---|
| 3 Month | 23.81% | 14.21% | 18.15% |
|---|
| Year-to-Date | 12.01% | 8.59% | 9.81% |
|---|
| 1 Year | 31.89% | 16.33% | 21.52% |
|---|
| 3 Year | 25.46% | 17.10% | 20.00% |
|---|
| 5 Year | 15.43% | 15.88% | 13.80% |
|---|
| 10 Year | 18.59% | 13.66% | 14.23% |
|---|
| Since Inception | 17.82% | 11.16% | -- |
|---|
Sector Allocation - BIOIX
as of 07/31/2025
| Basic Materials | | 0.00% |
|---|
| Consumer Cyclical | | 12.92% |
|---|
| Financial Services | | 6.19% |
|---|
| Real Estate | | 2.42% |
|---|
| Consumer Defensive | | 0.00% |
|---|
| Healthcare | | 8.90% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 13.91% |
|---|
| Energy | | 0.00% |
|---|
| Industrials | | 0.61% |
|---|
| Technology | | 55.05% |
|---|
Asset Allocation - BIOIX
as of 07/31/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | 90.39 | 90.39 |
|---|
| Bond | -- | | | 0.00 | 0.00 |
|---|
| Other | -- | | | 1.02 | 1.02 |
|---|
| Foreign Stock | -- | | | 5.77 | 5.77 |
|---|
| Foreign Bond | -- | | | 0.00 | 0.00 |
|---|
| Total | -- | | | 97.18 | 97.18 |
|---|
| Cash | -- | | | 0.69 | 0.69 |
|---|
| Total Net Assets | $1.71B |
|---|
| Total Stock Holdings | 45 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - BIOIX
as of 07/31/2025
Valuation & Growth - BIOIX
as of 07/31/2025
| Valuation | BIOIX | Category Range |
|---|
| Price/Earnings | 43.31 | |
|---|
| Price/Book | 10.81 | |
|---|
| Price/Sales | 9.66 | |
|---|
| Price/Cash Flow | 31.85 | |
|---|
| Dividend Yield | 0.29 | |
|---|
| LT Earnings | 13.66 | |
|---|
| Historical Earnings | 26.77 | |
|---|
| Sales Growth | 17.79 | |
|---|
| Cash-Flow Growth | 33.23 | |
|---|
| Book-Value Growth | 15.54 | |
|---|
